Aldeyra Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$37,542,510 over the previous period. Total operating expenses were $42,794,083.

Profit Margin

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): Profit margin
2014 0 -5.18M
2015 0 -12.09M
2016 0 -18.69M
2017 0 -22.34M
2018 0 -38.89M
2019 0 -60.82M
2020 0 -37.55M
2021 0 -59.25M
2022 0 -61.36M
2023 0 -37.54M

ALDX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
262.78K258.70K264.18K56.22K96.30K037.84K018.77K0
Gross profit
-262.78K-258.70K-264.18K-56.22K-96.30K0-37.84K0-18.77K0
Operating exp.
Research and development
29.45M47.30M44.93M24.68M44.35M29.82M16.30M13.17M7.57M3.70M
Selling and marketing
0000000000
Total operating expenses
42.79M62.67M56.21M34.66M56.50M39.69M22.48M18.69M11.98M7.27M
Operating income
-42.79M-62.67M-56.21M-36.42M-63.07M-39.69M-22.48M-18.69M-11.98M-7.27M
Other income (expenses), net
5.25M655.35K-1.55M-3.36M937.50K805.90K147.79K-3.47K-101.18K2.08M
Income before tax
-37.54M-62.02M-57.77M-38.03M-62.13M-38.89M-22.34M-18.69M-12.09M-5.18M
Income tax expense
0-655.35K1.47M-479.26K-1.30M952.69K223.40K66.24K-7.65K243.10K
Net income
-37.54M-61.36M-59.25M-37.55M-60.82M-38.89M-22.34M-18.69M-12.09M-5.18M
Earnings per share
Basic EPS
-0.64-1.05-1.1-1.11-2.24-1.79-1.4-1.65-1.4-1.36
Diluted EPS
-0.64-1.05-1.1-1.11-2.24-1.79-1.4-1.65-1.4-1.35
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source